Playback speed
10 seconds
ESMO 2023 Insights: "Survival Results for Neoadjuvant Cemiplimab in Patients With Resectable CSCC"
By
ecancer
FEATURING
Neil Gross
By
ecancer
FEATURING
Neil Gross
90 views
November 3, 2023
Login to view comments.
Click here to Login